Cannabigerol-d9

• CAT Number: R065226
• Molecular Formula: C21H23D9O2
• Molecular Weight: 325.5
• Purity: ≥95%
• Synonyms: CBG-d9
• Storage: -20°C
• IUPAC Name: 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-(2,2,3,3,4,4,5,5,5-nonadeuteriopentyl)benzene-1,3-diol
• InChI: InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+/i1D3,5D2,6D2,7D2
• InChIKey: QXACEHWTBCFNSA-QVVQTBGESA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O

Cannabigerol-d9 (CBG-d9) is a deuterated form of Cannabigerol, a non-psychoactive cannabinoid found in Cannabis plants. This labeled compound is employed in pharmacokinetic and metabolic studies to investigate the absorption, distribution, metabolism, and excretion of Cannabigerol in biological systems. In pharmaceutical research, CBG-d9 helps elucidate the metabolic pathways and potential therapeutic effects of Cannabigerol, which is being explored for its anti-inflammatory, antibacterial, and neuroprotective properties. Additionally, in organic chemistry, it supports the accurate quantification and tracing of Cannabigerol in complex biological matrices, aiding in the development of cannabinoid-based therapies.